Oscar Health, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $OSCR in the last 30 days.
See all $OSCR insider activity →Oscar Health, Inc. (OSCR) fell 6.99% to $30.99, underperforming broader market indices. The company's stock gained 15.41% over the past month. Analysts expect Q3 2026 EPS of -$0.11 and revenue of $4.72B, with full-year estimates of $1.83 EPS and $18.81B revenue. OSCR has a Zacks Rank of #1 (Strong Buy) and trades at a Forward P/E of 18.17.
Cleveland Clinic and Anthem Blue Cross are in contract dispute, risking out-of-network status for 113,000 Ohioans. Two carriers, CareSource and Molina, are exiting Ohio's individual market, affecting 54,000. Remaining insurers are raising rates by up to 24.1%. Open enrollment is complicated by these changes.
Oscar Health (NYSE:OSCR) is expanding its 2027 health insurance offerings to 21 states, including South Carolina, covering 713 counties. The company introduced RetireEase for early retirees and expanded HelloMeno for menopause care. It also partnered with Allstate Health Solutions and added 250 new plans with bundled dental and vision coverage. Enrollment begins November 1, 2026.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning OSCR (Oscar Health, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent OSCR coverage spans financial news, earnings and sector analysis.
The stock fell 6.99% and faces upcoming earnings on Nov 5, likely keeping short-term pressure.
Substantial premium increase may trigger member attrition and affect OSCR's growth outlook.
The expansion likely boosts enrollment and revenue outlook, creating upward pressure on the stock.
No fresh catalyst; the piece is a valuation commentary.
Analyst rating upgrade with higher price target may support modest upside.
AlphAI scores every news story that mentions OSCR with an AI model for sentiment and relevance, and aggregates insider trades from Oscar Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Oscar Health, Inc. (OSCR) fell 6.99% to $30.99, underperforming broader market indices. The company's stock gained 15.41% over the past month. Analysts expect Q3 2026 EPS of -$0.11 and revenue of $4.72B, with full-year estimates of $1.83 EPS and $18.81B revenue. OSCR has a Zacks Rank of #1 (Strong Buy) and trades at a Forward P/E of 18.17.
1 min readCleveland Clinic and Anthem Blue Cross are in contract dispute, risking out-of-network status for 113,000 Ohioans. Two carriers, CareSource and Molina, are exiting Ohio's individual market, affecting 54,000. Remaining insurers are raising rates by up to 24.1%. Open enrollment is complicated by these changes.
3 min readOscar Health (NYSE:OSCR) is expanding its 2027 health insurance offerings to 21 states, including South Carolina, covering 713 counties. The company introduced RetireEase for early retirees and expanded HelloMeno for menopause care. It also partnered with Allstate Health Solutions and added 250 new plans with bundled dental and vision coverage. Enrollment begins November 1, 2026.
2 min readOscar Health (OSCR) reported record earnings, rising revenue, and growing membership, raising questions about its valuation. The stock trades at 18.9x earnings, above the insurance sector average but below its peer group. Analysts are divided, with some seeing it as 94% undervalued and others as 30% overvalued, depending on future growth and risk factors.
2 min readUBS maintained a 'Neutral' rating for Oscar Health (OSCR) but raised its price target to $36 from $26. GuruFocus values OSCR at $24.66, suggesting it is 37.9% overvalued at $34.01. The company has a GF Score of 81/100, with strong growth and momentum but concerns over valuation and profitability. Insiders have sold $26.76M in shares over the past three months.
2 min readOscar Health (OSCR) reported Q2 2026 revenue of $4.88B, up from $2.86B in 2025, with net income of $361.8M. The company raised 2026 operating earnings guidance to $600-800M. Shares surged 130% YTD, closing at $33.10 on Oct 8, 2026. Growth plans include expanding into 150+ metro areas by 2027, but risks include ACA subsidy uncertainty and rising medical costs.
2 min readWITTMAN VANESSA AMES sold 25,000 shares of Oscar Health, Inc. (OSCR) at $32.24 ($0.81M total) on 2026-09-18 under a Rule 10b5-1 trading plan.
1 min readThe Trump administration plans to remove 750,000 ACA enrollees due to alleged fraud, saving $2.2B. Affected individuals include those unaware of enrollments, high earners, and those with employer-provided healthcare. Leading ACA marketplace operators traded lower on the news.
2 min readPiper Sandler raised its price target for Oscar Health (OSCR) to $48, citing ACA growth and a 12x multiple on 2030 earnings. The stock has surged 139% in six months, with analysts predicting profitability this year. Oscar Health reported strong Q2 2026 results, exceeding earnings and revenue expectations, and raised its 2026 guidance.
2 min readAnalysts adjusted ratings and price targets for several companies. HSBC downgraded Copart to hold, lowering its target to $36. Bernstein downgraded Palo Alto Networks and SentinelOne but raised their targets. Fortinet's target was raised by Bernstein, while Pegasystems' was cut by JP Morgan. Other companies affected include J&J, Generac, Mks, Oscar Health, and Wingstop.
2 min read
